Nuvei assumed with an Outperform at BMO Capital

BMO Capital assumed coverage of Nuvei with an Outperform rating and $30 price target. Nuvei reported “solid” Q3 results following “a series of tricky quarters,” says the analyst, who believes consistency is the key demand from investors. Shares remain deeply discounted and the firm believes that sentiment around the stock is “negative enough” that simply meeting the company’s recently reduced and derisked guidance will drive share price outperformance, the analyst tells investors.